Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman(The University of Texas MD Anderson Cancer Center), Amit M. Oza(University Health Network), Domenica Lorusso(Fondazione IRCCS Istituto Nazionale dei Tumori), Carol Aghajanian(Memorial Sloan Kettering Cancer Center), Ana Oaknin(Vall d'Hebron Hospital Universitari), Andrew Dean(St John of God Subiaco Hospital), Nicoletta Colombo(University of Milan), Johanne I. Weberpals(Ottawa Hospital), Andrew R. Clamp(National Health Service), Giovanni Scambia(Università Cattolica del Sacro Cuore), Alexandra Léary(Inserm), Robert W. Holloway(Florida Hospital Cancer Institute), Margarita Amenedo(Centro Oncológico de Galicia), Peter C.C. Fong(Auckland City Hospital), Jeffrey C. Goh(Royal Brisbane and Women's Hospital), David M. O’Malley(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Deborah K. Armstrong(Sidney Kimmel Comprehensive Cancer Center), Jesús García-Donás(HM Hospitales), Elizabeth M. Swisher(University of Washington), Anne Floquet(Institut Bergonié), Gottfried E. Konecny(University of California, Los Angeles), Iain A. McNeish(University of Glasgow), Clare L. Scott(The Royal Melbourne Hospital), T. Cameron(Clovis Oncology (United States)), Lara Maloney(Clovis Oncology (United States)), Jeff Isaacson(Clovis Oncology (United States)), Sandra Goble(Clovis Oncology (United States)), Caroline A. Grace(Clovis Oncology (United States)), Thomas C. Harding(Clovis Oncology (United States)), Mitch Raponi(Clovis Oncology (United States)), James Sun(Foundation Medicine (United States)), Kevin Lin(Clovis Oncology (United States)), Heidi Giordano(Clovis Oncology (United States)), Jonathan A. Ledermann(Royal London Hospital), Martin Buck(Royal London Hospital), Andrew Dean(St John of God Subiaco Hospital), Michael Friedländer, Jeffrey C. Goh(Royal Brisbane and Women's Hospital), Paul R. Harnett(Royal London Hospital), Ganessan Kichenadasse(Clovis Oncology (United States)), Clare L. Scott(The Royal Melbourne Hospital), Hannelore Denys(Royal London Hospital), Luc Dirix(CRUK Lung Cancer Centre of Excellence), Ignace Vergote(Clovis Oncology (United States)), Laurie Elit(CRUK Lung Cancer Centre of Excellence), Prafull Ghatage(Royal London Hospital), Amit M. Oza(University Health Network), Marie Plante(Royal London Hospital), Diane Provencher(Royal London Hospital), Johanne I. Weberpals(Ottawa Hospital), Stephen Welch(Foundation Medicine (United States)), Anne Floquet(Institut Bergonié), Laurence Gladieff(CRUK Lung Cancer Centre of Excellence), Florence Joly(Royal London Hospital), Alexandra Léary(Inserm), Alain Lortholary, Jean‐Pierre Lotz(Royal London Hospital), Jacques Médioni(Royal London Hospital), Olivier Trédan(CRUK Lung Cancer Centre of Excellence), Benoît You(Clovis Oncology (United States)), Ayşe Balat, Claudia Hänle(Royal London Hospital), Petra Krabisch(Royal London Hospital), Tanja Neunhöffer(CRUK Lung Cancer Centre of Excellence), Martin Pölcher(Royal London Hospital), Pauline Wimberger(Royal London Hospital), A Amit(University Health Network), Svetlana Kovel(Foundation Medicine (United States)), Michelle Leviov(Royal London Hospital), Tamar Safra(CRUK Lung Cancer Centre of Excellence), Ronnie Shapira‐Frommer(CRUK Lung Cancer Centre of Excellence), Salomon M. Stemmer(Foundation Medicine (United States)), Alessandra Bologna, Nicoletta Colombo(University of Milan), Domenica Lorusso(Fondazione IRCCS Istituto Nazionale dei Tumori), Sandro Pignata(Foundation Medicine (United States)), Roberto Sabbatini(Auckland City Hospital), Giovanni Scambia(Università Cattolica del Sacro Cuore), Stefano Tamberi(Foundation Medicine (United States)), Claudio Zamagni(Clovis Oncology (United States)), Peter C.C. Fong(Auckland City Hospital), Anne O’Donnell, Margarita Amenedo(Centro Oncológico de Galicia), A. Casado Herráez, Jesús García-Donás(HM Hospitales), E.M. Guerra(Clovis Oncology (United States)), Ana Oaknin(Vall d'Hebron Hospital Universitari), Isabel Palacio(Clovis Oncology (United States)), Ignacio Romero(Clovis Oncology (United States)), A Sanchez, Susana Banerjee, Andrew R. Clamp(National Health Service), Yvette Drew(National Health Service), Hani Gabra, D Jackson(Royal London Hospital), JA Ledermann(Royal London Hospital), Iain A. McNeish(University of Glasgow), C. A. Parkinson(Clovis Oncology (United States)), Melanie Powell(Royal London Hospital), Carol Aghajanian(Memorial Sloan Kettering Cancer Center), Deborah K. Armstrong(Sidney Kimmel Comprehensive Cancer Center), Michael J. Birrer, Mary K. Buss, Suzanne K. Chambers, LM Chen, Robert L. Coleman(The University of Texas MD Anderson Cancer Center), Robert W. Holloway(Florida Hospital Cancer Institute), Gottfried E. Konecny(University of California, Los Angeles), Ling Ma(Royal London Hospital), Mark A. Morgan(Royal London Hospital), Ronnie Morris(Florida Hospital Cancer Institute), David G. Mutch, David M. O’Malley(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Brian M. Slomovitz, Elizabeth M. Swisher(University of Washington), Timothy J. Vanderkwaak(CRUK Lung Cancer Centre of Excellence), Michel Vulfovich(Royal London Hospital)
Cited by 1,700Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis